Short- and Long-Term Efficacy and Safety of Deep-Brain Stimulation in Parkinson’s Disease Patients aged 75 Years and Older

Short- and Long-Term Efficacy and Safety of Deep-Brain Stimulation in Parkinson’s Disease Patients aged 75 Years and Older
Brain Sci. 2022 Nov 20;12(11):1588. doi: 10.3390/brainsci12111588.ABSTRACTOBJECTIVE: The aim of this study was to investigate the efficacy and safety of deep-brain stimulation (DBS) in the treatment of patients with Parkinson's disease aged 75 years and older.METHODS: From March 2013 to June 2021, 27 patients with Parkinson's disease (≥75 years old) who underwent DBS surgery at the First Medical Center of ... read more
Source: PubMedPublished on 2022-11-24By Chao Jiang